It is well known that launching a new UKCA or EU MDR approved or established AI software solutions or novel technologies into a new healthcare market or country is a complex business.

Our experienced and recognised consultants are here to support your new AI technology, in the fields of cancer treatment, cardiology, medical imaging and diagnostics, through this process.

We will provide you with:

• Assistance with achieving the requirements for UK IT, digital and cyber security.

• A direct personalised approach to Hospitals, physicians, and scientific or clinical lead groups

• Business Development

• Brand Awareness with the focused marketing and publicity

• Clinical Collaborations for real-world clinical proof of your technology

• Market analysis, including Competitor Landscape, Market Penetration, Strategic Insight and Planning.

AMG Medtech can use either key project milestones or other mutually agreed deliverables, giving transparency to our clients, and placing the emphasis on the quality of our work.

You will expect to grow your AI software business to the benefit customers and patients, and feel confident that AMG Medtech will deliver the results to enhance or transform your business.

By collaborating with you, we tailor and deliver strategies to assist you through this complex processes, address your challenges and achieve your business goals.

We give you proactive advice and communication to help you work with your clients from the end user customer to other external stakeholders.

Talk to AMG Medtech for full support to launch your established or new groundbreaking technologies and AI software solutions, with clinical proof-cases and papers.